/UBIO
UBIO

UBIO Stock - ProShares UltraPro Nasdaq Biotechnology

Financial Services|Asset Management - Leveraged
$17.77+0.00%
+$0.00 (+0.00%) • Mar 27
47
GoAI Score
HOLD
Medium Confidence
Momentum
50
Sentiment
70
Risk Score
0
Price Target
+10.0%upside
Target: $19.54
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing

Unlock GoAI Insights for UBIO

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis

Free 14-day trial • No credit card required

Frequently Asked Questions about UBIO

What is UBIO's current stock price?
ProShares UltraPro Nasdaq Biotechnology (UBIO) is currently trading at $17.77 per share. The stock has moved +0.00% today.
What is the analyst price target for UBIO?
No analyst price targets are currently available for this stock.
What sector is ProShares UltraPro Nasdaq Biotechnology in?
ProShares UltraPro Nasdaq Biotechnology operates in the Financial Services sector, specifically within the Asset Management - Leveraged industry. The company is traded on the NASDAQ exchange.
What is UBIO's market cap?
ProShares UltraPro Nasdaq Biotechnology has a market capitalization of $0.02 billion, making it a small-cap company.
Does UBIO pay dividends?
No, ProShares UltraPro Nasdaq Biotechnology does not currently pay a dividend to shareholders.

Similar Stocks

Financial Services Sector

Explore stocks similar to UBIO for comparison